Shift Bioscience

Shift Bioscience is a biotech company in Cambridge, United Kingdom, founded in 2017. It has raised $16.0M across 1 round, most recently a $16.0M Seed in October 2024.

Cell rejuvenation to rewind age driven diseases.

Headquarters
Cambridge
Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$16.0M
Last Round
$16.0M SeedOct 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

Shift Bioscience is targeting the underlying cause of age driven diseases, the aging cell. Shift Bioscience has combined a novel aging clock (AC4) and virtual cell model to remove the primary bottleneck for discovery of cellular aging and rejuvenation targets, experimental throughput. This enables the discovery of hundreds of novel targets including those linked to disease states. Its product is an anti-fibrotic siRNA therapeutic for cell rejuvenation, and SB101 knockdown reverses epigenetic aging clocks in multiple cell types.

Summary

It lists 1–10 employees. It has raised $16.0M in total across 1 round, most recently a $16.0M Seed round in Oct 2024. Investors include BGF, F-Prime Capital and Kindred Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundOct 2024
$16.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Shift Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/shift-bioscience"><img src="https://indexed.vc/api/badge/company/shift-bioscience" alt="Shift Bioscience on Indexed.vc" width="260" height="76" /></a>